Protagonist Therapeutics PTGX Earnings Call Transcripts

NASDAQ PTGX
$134.86 -1.40 (-1.03%)
At close: Nov 11, 2026 · 4:00 PM EST
2 earnings calls on file for Protagonist Therapeutics, from Q1 2020 to Mar 10, 2021. Each transcript opens in a new tab.
Latest earnings call

Protagonist Therapeutics Earnings Call, Mar 10, 2021

Mar 10, 2021 3,937 words · 17 min read
  • Dinesh PatelChief Executive Officer
  • Samuel SaksChief Medical Officer
  • David LiuChief Scientific Officer
  • Suneel GuptaChief Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Protagonist Therapeutics Earnings Call Transcripts

Calls2
LatestMar 10, 2021
SinceQ1 2020

Fiscal 2021

Fiscal 2020

All 2 Protagonist Therapeutics transcripts Register to get access to Protagonist Therapeutics’s earnings call transcripts.